Increasing Geriatric Population Prone To COPD And Other Respiratory Disorders Is Expected To Bolster Growth

Global Medical Oxygen Concentrators Market is expected to reach USD 2.10 billion by 2022, according to a new study by Grand View Research, Inc. Increasing geriatric population with lower immunity levels prone to various medical conditions such as COPD and other respiratory disorders is expected to remain a key factor driving the medical oxygen concentrators market over the forecast period. Presence of favorable government initiatives including the presence of advisory circulars pertaining to the usage of portable oxygen concentrators which meet the applicable FAA requirements is also expected to drive market growth. Growing healthcare expenditure levels triggering the demand for home healthcare is likely to boost the demand for portable devices.

Medical oxygen concentrators market, by application, 2012 - 2022 (USD Million)


Home care services were the largest application segment in 2014. Key factors attributing to its large share include the rising demand for home oxygen concentrators that help with shortness of breath and increasing prevalence of COPD. Non home care services are also expected to witness lucrative growth over the forecast period majorly owing to, the ever increasing procedure volume in non home health care settings.

Browse full research report on Medical Oxygen Concentrators Market: www.grandviewresearch.com/industry-analysis/medical-oxygen-concentrators-market       
                                                                                              
Further Key Findings From the Study Suggest:

  • Continuous flow technology based devices were the most revenue generating segment in 2014. Key factors attributing to its market dominance include the product’s ability to supply pure oxygen to users with improved battery power in all circumstances.
  • Portable oxygen concentrators are expected to witness lucrative growth of over 13.0% during the forecast period. Factors such as increasing geriatric population, rising prevalence of respiratory diseases, and features such as light weightiness and user friendliness are expected to ensure expedited segment growth.
  • Fixed medical oxygen concentrators dominated the overall market, valued at over USD 400.0 million in 2014. High usage rates associated with the product, especially in non home healthcare settings is a key factor accounting to the segment’s market position.
  • North America touted the highest market penetration rates in 2014. Presence of sophisticated healthcare infrastructure and favorable reimbursement policies is expected to drive regional market over the forecast period.
  • Asia Pacific is identified as the fastest growing oxygen concentrators market. High growth opportunities available in the emerging markets of India and China coupled with rapidly growing disease prevalence levels are some factors expected to drive regional market over the forecast period.
  • Key players operating in the medical oxygen concentrators market include Teijin Limited, Invacare Corporation, Devilbiss Healthcare, AirSep Corporation, Inova Labs, Philips Healthcare, Nidek Medical Products, Inogen Inc., O2 Concepts and Covidien Ltd.,

Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/medical-devices 

                                                                                                   
Grand View Research has segmented the medical oxygen concentrators market on the basis of product, application, technology and region:

Global Medical Oxygen Concentrators Product Outlook (Revenue, USD Million, 2012 - 2022)
  • Portable oxygen concentrators
  • Fixed  oxygen concentrators
Global Medical Oxygen Concentrators Application Outlook (Revenue, USD Million, 2012 - 2022)
  • Home care
  • Non home care
Global Medical Oxygen Concentrators Technology Outlook (Revenue, USD Million, 2012 - 2022
  • Continuous flow
  • Pulse dose
Medical Oxygen Concentrators Regional Outlook (Revenue, USD Million, 2012 - 2022)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • MEA
    • South Africa
  • Latin America
    • Brazil

Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-medical-oxygen-concentrators-market 
                                                           

About Grand View Research:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: www.grandviewresearch.com

Comments

  1. Unknown14 February 2018 at 00:35

    I have had emphysema for about five years. I was on oxygen during the day but not at night. I could go about two hours without the oxygen, and then I need it. I had a converter in the house and oxygen tanks for when I go shopping, etc. I am 64 years old and in relatively good health. The doctor said it was caused by a combination of smoking, dust here in Vegas, and 30 years of smog in California. I believed I will always need the oxygen to breathe. I quit smoking 15 years ago. But the damage has been done. January 2017 my pulmonologist and I decided to go with natural treatment and was introduced to Green House Herbal Clinic natural organic Emphysema Herbal formula, i had a total decline of symptoms with this Emphysema Herbal formula treatment. Visit Green House Herbal Clinic official web-site ww w. greenhouseherbalclinic. com. The infections, shortness of breath, fatigue, dry cough and other symptoms has subsided.  I am very pleased with this treatment. I breath very well now and exercise regularly, sometimes i totally forget i ever had Emphysema, I am thankful to nature, the medics failed. Share with friends!!

    ReplyDelete

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more